Transmembrane chemokines act as receptors in a novel mechanism termed inverse signaling
about
The DRF motif of CXCR6 as chemokine receptor adaptation to adhesion.The Chemokine Receptor CXCR6 Evokes Reverse Signaling via the Transmembrane Chemokine CXCL16.Novel Chemokine-Based Immunotoxins for Potent and Selective Targeting of Cytomegalovirus Infected Cells."Inverse signaling" of the transmembrane chemokine CXCL16 contributes to proliferative and anti-apoptotic effects in cultured human meningioma cells.In-depth immunophenotyping of patients with glioblastoma multiforme: Impact of steroid treatment.Chemokine CXCL16 mediates acinar cell necrosis in cerulein induced acute pancreatitis in mice.
P2860
Transmembrane chemokines act as receptors in a novel mechanism termed inverse signaling
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Transmembrane chemokines act as receptors in a novel mechanism termed inverse signaling
@ast
Transmembrane chemokines act as receptors in a novel mechanism termed inverse signaling
@en
Transmembrane chemokines act as receptors in a novel mechanism termed inverse signaling
@nl
type
label
Transmembrane chemokines act as receptors in a novel mechanism termed inverse signaling
@ast
Transmembrane chemokines act as receptors in a novel mechanism termed inverse signaling
@en
Transmembrane chemokines act as receptors in a novel mechanism termed inverse signaling
@nl
prefLabel
Transmembrane chemokines act as receptors in a novel mechanism termed inverse signaling
@ast
Transmembrane chemokines act as receptors in a novel mechanism termed inverse signaling
@en
Transmembrane chemokines act as receptors in a novel mechanism termed inverse signaling
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
Transmembrane chemokines act as receptors in a novel mechanism termed inverse signaling
@en
P2093
Henrike Gebhardt
Janka Held-Feindt
Kirsten Hattermann
Ralph Lucius
P2860
P304
P3181
P356
10.7554/ELIFE.10820
P407
P577
2016-01-21T00:00:00Z